INS and metabolic dysfunction-associated steatotic liver disease: The positive effect of liraglutide co-treatment with metformin in obese diabetic patients with NAFLD was also proven by Guo et al. This research proved the efficiency of this composition in reducing liver steatosis, ALT, AST, insulin resistance factor and visceral and abdominal fat [120].